Human CLEC10A/CD301 Biotinylated Antibody Summary
Gln61-His316
Accession # Q8IUN9
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CLEC10A/CD301
CLEC10A, also known as macrophage galactose/N-acetyl-galactosamine (GalNAc) specific lectin (MGL), CD301, DC-ASGPR, and HML, is a 40 kDa type II transmembrane glycoprotein that belongs to the C-type lectin family (1). Human and rat carry a single gene for CLEC10A/MGL, while mouse has two closely related MGL1 and MGL2 genes. Human CLEC10A/MGL consists of a 39 amino acid (aa) cytoplasmic region, a 21 aa transmembrane segment and a 256 aa extracellular domain (ECD) with one carbohydrate recognition domain (CRD) and a neck region (2). Within the CRD, human CLEC10A/MGL shares 64% - 70% aa sequence identity with mouse MGL1, mouse MGL2, and rat MGL. Alternate splicing generates multiple isoforms of human CLEC10A/MGL with 27 aa, 3 aa, and/or 4 aa deletions within the ECD (3, 4). CLEC10A/MGL is expressed on immature myleloid dendritic cells and alternatively activated (tolerogenic) macrophages and is up-regulated by the immunosuppressant dexamethasone (3-7). CLEC10A/MGL selectively binds and internalizes terminal nonsialylated alpha - or beta -linked GalNAc moieties on O-linked carbohydrates, including the Tn carcinoma antigen (2-4, 8, 9). Similar ligand preference is exhibited by mouse MGL2 but not MGL1 (10). CLEC10A/MGL expressed on tolerogenic dendritic cells binds carbohydrate determinants on CD45 (RA, RB, and RC but not RO isoforms) expressed by T, NK, and B cells (6). This interaction inhibits effector T cell activation and induces their apoptosis (6). CLEC10A/MGL also binds the GP envelope glycoprotein on Marburg and Ebola viruses and enhances viral entry and infectivity (11).
- Zelensky, A.N. and J.E. Gready (2005) FEBS J. 272:6179.
- Suzuki, N. et al. (1996) J. Immunol. 156:128.
- Higashi, N. et al. (2002) J. Biol. Chem. 277:20686.
- Valladeau, J. et al. (2001) J. Immunol. 167:5767.
- van Vliet, S.J. et al. (2006) Immunobiology 211:577.
- van Vliet, S.J. et al. (2006) Nat. Immunol. 7:1200.
- Raes, G. et al. (2005) J. Leukoc. Biol. 77:321.
- van Vliet, S.J. et al. (2005) Int. Immunol. 17:661.
- Higashi, N. et al. (2002) Int. Immunol. 14:545.
- Tsuiji, M. et al. (2002) J. Biol. Chem. 277:28892.
- Takada, A. et al. (2004) J. Virol. 78:2943.
Product Datasheets
Citation for Human CLEC10A/CD301 Biotinylated Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides
Authors: LL Eggink, KF Roby, R Cote, J Kenneth Ho
J Immunother Cancer, 2018-04-17;6(1):28.
Species: Human
Sample Types: Recombinant Protein
Applications: ELISA Detection
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human CLEC10A/CD301 Biotinylated Antibody
There are currently no reviews for this product. Be the first to review Human CLEC10A/CD301 Biotinylated Antibody and earn rewards!
Have you used Human CLEC10A/CD301 Biotinylated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
